AVIR - Company ID 0001593899
Atea Pharmaceuticals, Inc. has filed 301 public company documents between 2013 and 2026. The most frequent type is insider trade (98 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SCHEDULE 13G/A | SCHEDULE 13G/A | 7mo ago2025-12-05 | - | View filing |
| 10-Q | Quarterly report | 8mo ago2025-11-12 | 2025-09-30 | View filing |
| 8-K | Major company event | 8mo ago2025-11-12 | 2025-11-12 | View filing |
| S-8 | Employee stock plan | 11mo ago2025-08-07 | - | View filing |
| 8-K | Major company event | 11mo ago2025-08-07 | 2025-08-07 | View filing |
| 10-Q | Quarterly report | 11mo ago2025-08-07 | 2025-06-30 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-06 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 4 | Insider trade | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 3 | New insider ownership | 1y ago2025-06-24 | 2025-06-20 | View filing |
| 8-K | Major company event | 1y ago2025-06-20 | 2025-06-20 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-14 | - | View filing |
| 8-K | Major company event | 1y ago2025-05-12 | 2025-05-12 | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-12 | 2025-03-31 | View filing |
| DEF 14A | Proxy statement | 1y ago2025-04-29 | 2025-06-20 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-04-23 | - | View filing |
| 8-K | Major company event | 1y ago2025-04-17 | 2025-04-16 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-04-17 | - | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-03 | - | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-01 | - | View filing |
| 8-K | Major company event | 1y ago2025-04-01 | 2025-03-31 | View filing |
| DEFA14A | Proxy materials | 1y ago2025-03-26 | - | View filing |
| DFAN14A | DFAN14A | 1y ago2025-03-26 | - | View filing |
| DEFA14A | Proxy materials | 1y ago2025-03-24 | - | View filing |
| 8-K | Major company event | 1y ago2025-03-24 | 2025-03-21 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-03-21 | - | View filing |
| 8-K | Major company event | 1y ago2025-03-06 | 2025-03-06 | View filing |
| 10-K | Annual report | 1y ago2025-03-06 | 2024-12-31 | View filing |
| SCHEDULE 13D | SCHEDULE 13D | 1y ago2025-03-04 | - | View filing |
| 8-K | Major company event | 1y ago2025-02-24 | 2025-02-20 | View filing |
| 4 | Insider trade | 1y ago2025-02-24 | 2025-02-20 | View filing |
| 3 | New insider ownership | 1y ago2025-02-24 | 2025-02-20 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-14 | - | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4 | Insider trade | 1y ago2025-02-04 | 2025-01-31 | View filing |
| 4/A | Insider trade (amended) | 1y ago2025-01-17 | 2025-01-15 | View filing |
| 4 | Insider trade | 1y ago2025-01-17 | 2025-01-15 | View filing |
| 8-K | Major company event | 1y ago2025-01-14 | 2025-01-13 | View filing |